1078 related articles for article (PubMed ID: 30936547)
1. Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer.
Wirbel J; Pyl PT; Kartal E; Zych K; Kashani A; Milanese A; Fleck JS; Voigt AY; Palleja A; Ponnudurai R; Sunagawa S; Coelho LP; Schrotz-King P; Vogtmann E; Habermann N; Niméus E; Thomas AM; Manghi P; Gandini S; Serrano D; Mizutani S; Shiroma H; Shiba S; Shibata T; Yachida S; Yamada T; Waldron L; Naccarati A; Segata N; Sinha R; Ulrich CM; Brenner H; Arumugam M; Bork P; Zeller G
Nat Med; 2019 Apr; 25(4):679-689. PubMed ID: 30936547
[TBL] [Abstract][Full Text] [Related]
2. Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer Pathogenesis.
Kim M; Vogtmann E; Ahlquist DA; Devens ME; Kisiel JB; Taylor WR; White BA; Hale VL; Sung J; Chia N; Sinha R; Chen J
mBio; 2020 Feb; 11(1):. PubMed ID: 32071266
[TBL] [Abstract][Full Text] [Related]
3. Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation.
Thomas AM; Manghi P; Asnicar F; Pasolli E; Armanini F; Zolfo M; Beghini F; Manara S; Karcher N; Pozzi C; Gandini S; Serrano D; Tarallo S; Francavilla A; Gallo G; Trompetto M; Ferrero G; Mizutani S; Shiroma H; Shiba S; Shibata T; Yachida S; Yamada T; Wirbel J; Schrotz-King P; Ulrich CM; Brenner H; Arumugam M; Bork P; Zeller G; Cordero F; Dias-Neto E; Setubal JC; Tett A; Pardini B; Rescigno M; Waldron L; Naccarati A; Segata N
Nat Med; 2019 Apr; 25(4):667-678. PubMed ID: 30936548
[TBL] [Abstract][Full Text] [Related]
4. Multimodal metagenomic analysis reveals microbial single nucleotide variants as superior biomarkers for early detection of colorectal cancer.
Gao W; Gao X; Zhu L; Gao S; Sun R; Feng Z; Wu D; Liu Z; Zhu R; Jiao N
Gut Microbes; 2023 Dec; 15(2):2245562. PubMed ID: 37635357
[TBL] [Abstract][Full Text] [Related]
5. Establishing a novel colorectal cancer predictive model based on unique gut microbial single nucleotide variant markers.
Ma C; Chen K; Wang Y; Cen C; Zhai Q; Zhang J
Gut Microbes; 2021; 13(1):1-6. PubMed ID: 33430705
[TBL] [Abstract][Full Text] [Related]
6. Altered Mycobiota Signatures and Enriched Pathogenic Aspergillus rambellii Are Associated With Colorectal Cancer Based on Multicohort Fecal Metagenomic Analyses.
Lin Y; Lau HC; Liu Y; Kang X; Wang Y; Ting NL; Kwong TN; Han J; Liu W; Liu C; She J; Wong SH; Sung JJ; Yu J
Gastroenterology; 2022 Oct; 163(4):908-921. PubMed ID: 35724733
[TBL] [Abstract][Full Text] [Related]
7. Altered Gut Archaea Composition and Interaction With Bacteria Are Associated With Colorectal Cancer.
Coker OO; Wu WKK; Wong SH; Sung JJY; Yu J
Gastroenterology; 2020 Oct; 159(4):1459-1470.e5. PubMed ID: 32569776
[TBL] [Abstract][Full Text] [Related]
8. Consistent signatures in the human gut microbiome of old- and young-onset colorectal cancer.
Qin Y; Tong X; Mei WJ; Cheng Y; Zou Y; Han K; Yu J; Jie Z; Zhang T; Zhu S; Jin X; Wang J; Yang H; Xu X; Zhong H; Xiao L; Ding PR
Nat Commun; 2024 Apr; 15(1):3396. PubMed ID: 38649355
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota dysbiosis signature is associated with the colorectal carcinogenesis sequence and improves the diagnosis of colorectal lesions.
Gao R; Wang Z; Li H; Cao Z; Gao Z; Chen H; Zhang X; Pan D; Yang R; Zhong H; Shen R; Yin L; Jia Z; Shen T; Qin N; Hu Z; Qin H
J Gastroenterol Hepatol; 2020 Dec; 35(12):2109-2121. PubMed ID: 32337748
[TBL] [Abstract][Full Text] [Related]
10. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer.
Yu J; Feng Q; Wong SH; Zhang D; Liang QY; Qin Y; Tang L; Zhao H; Stenvang J; Li Y; Wang X; Xu X; Chen N; Wu WK; Al-Aama J; Nielsen HJ; Kiilerich P; Jensen BA; Yau TO; Lan Z; Jia H; Li J; Xiao L; Lam TY; Ng SC; Cheng AS; Wong VW; Chan FK; Xu X; Yang H; Madsen L; Datz C; Tilg H; Wang J; Brünner N; Kristiansen K; Arumugam M; Sung JJ; Wang J
Gut; 2017 Jan; 66(1):70-78. PubMed ID: 26408641
[TBL] [Abstract][Full Text] [Related]
11. Alterations of circulating bacterial DNA in colorectal cancer and adenoma: A proof-of-concept study.
Xiao Q; Lu W; Kong X; Shao YW; Hu Y; Wang A; Bao H; Cao R; Liu K; Wang X; Wu X; Zheng S; Yuan Y; Ding K
Cancer Lett; 2021 Feb; 499():201-208. PubMed ID: 33249197
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer microbiome programs DNA methylation of host cells by affecting methyl donor metabolism.
Liu Z; Zhang Q; Zhang H; Yi Z; Ma H; Wang X; Wang J; Liu Y; Zheng Y; Fang W; Huang P; Liu X
Genome Med; 2024 Jun; 16(1):77. PubMed ID: 38840170
[TBL] [Abstract][Full Text] [Related]
13. Different Characteristics in Gut Microbiome between Advanced Adenoma Patients and Colorectal Cancer Patients by Metagenomic Analysis.
Han S; Zhuang J; Pan Y; Wu W; Ding K
Microbiol Spectr; 2022 Dec; 10(6):e0159322. PubMed ID: 36453905
[TBL] [Abstract][Full Text] [Related]
14. Multi-kingdom microbiota analyses identify bacterial-fungal interactions and biomarkers of colorectal cancer across cohorts.
Liu NN; Jiao N; Tan JC; Wang Z; Wu D; Wang AJ; Chen J; Tao L; Zhou C; Fang W; Cheong IH; Pan W; Liao W; Kozlakidis Z; Heeschen C; Moore GG; Zhu L; Chen X; Zhang G; Zhu R; Wang H
Nat Microbiol; 2022 Feb; 7(2):238-250. PubMed ID: 35087227
[TBL] [Abstract][Full Text] [Related]
15. Changes in gut microbiota and plasma inflammatory factors across the stages of colorectal tumorigenesis: a case-control study.
Zhang Y; Yu X; Yu E; Wang N; Cai Q; Shuai Q; Yan F; Jiang L; Wang H; Liu J; Chen Y; Li Z; Jiang Q
BMC Microbiol; 2018 Aug; 18(1):92. PubMed ID: 30157754
[TBL] [Abstract][Full Text] [Related]
16. Development of a colorectal cancer diagnostic model and dietary risk assessment through gut microbiome analysis.
Yang J; McDowell A; Kim EK; Seo H; Lee WH; Moon CM; Kym SM; Lee DH; Park YS; Jee YK; Kim YK
Exp Mol Med; 2019 Oct; 51(10):1-15. PubMed ID: 31582724
[TBL] [Abstract][Full Text] [Related]
17. Alterations in Enteric Virome Are Associated With Colorectal Cancer and Survival Outcomes.
Nakatsu G; Zhou H; Wu WKK; Wong SH; Coker OO; Dai Z; Li X; Szeto CH; Sugimura N; Lam TY; Yu AC; Wang X; Chen Z; Wong MC; Ng SC; Chan MTV; Chan PKS; Chan FKL; Sung JJ; Yu J
Gastroenterology; 2018 Aug; 155(2):529-541.e5. PubMed ID: 29689266
[TBL] [Abstract][Full Text] [Related]
18. Integrated Analysis of Colorectal Cancer Reveals Cross-Cohort Gut Microbial Signatures and Associated Serum Metabolites.
Gao R; Wu C; Zhu Y; Kong C; Zhu Y; Gao Y; Zhang X; Yang R; Zhong H; Xiong X; Chen C; Xu Q; Qin H
Gastroenterology; 2022 Oct; 163(4):1024-1037.e9. PubMed ID: 35788345
[TBL] [Abstract][Full Text] [Related]
19. Integrated analysis of the faecal metagenome and serum metabolome reveals the role of gut microbiome-associated metabolites in the detection of colorectal cancer and adenoma.
Chen F; Dai X; Zhou CC; Li KX; Zhang YJ; Lou XY; Zhu YM; Sun YL; Peng BX; Cui W
Gut; 2022 Jul; 71(7):1315-1325. PubMed ID: 34462336
[TBL] [Abstract][Full Text] [Related]
20. Colorectal cancer-associated microbiota contributes to oncogenic epigenetic signatures.
Sobhani I; Bergsten E; Couffin S; Amiot A; Nebbad B; Barau C; de'Angelis N; Rabot S; Canoui-Poitrine F; Mestivier D; Pédron T; Khazaie K; Sansonetti PJ
Proc Natl Acad Sci U S A; 2019 Nov; 116(48):24285-24295. PubMed ID: 31712445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
